- Home
- DOYU vs LAB Comparison
DOYU vs LAB Comparison
Compare DOYU & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOYU
- LAB
- Stock Information
- Founded
- DOYU 2014
- LAB 1999
- Country
- DOYU China
- LAB United States
- Employees
- DOYU N/A
- LAB N/A
- Industry
- DOYU Computer Software: Programming Data Processing
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- DOYU Technology
- LAB Industrials
- Exchange
- DOYU Nasdaq
- LAB Nasdaq
- Market Cap
- DOYU 485.3M
- LAB 562.1M
- IPO Year
- DOYU 2019
- LAB 2011
- Fundamental
- Price
- DOYU $7.20
- LAB $1.30
- Analyst Decision
- DOYU Strong Sell
- LAB Strong Buy
- Analyst Count
- DOYU 3
- LAB 2
- Target Price
- DOYU $7.03
- LAB $2.88
- AVG Volume (30 Days)
- DOYU 281.8K
- LAB 1.8M
- Earning Date
- DOYU 03-25-2025
- LAB 02-26-2025
- Dividend Yield
- DOYU 545.83%
- LAB N/A
- EPS Growth
- DOYU N/A
- LAB N/A
- EPS
- DOYU N/A
- LAB N/A
- Revenue
- DOYU $631,661,209.00
- LAB $155,902,000.00
- Revenue This Year
- DOYU N/A
- LAB $62.60
- Revenue Next Year
- DOYU N/A
- LAB $9.19
- P/E Ratio
- DOYU N/A
- LAB N/A
- Revenue Growth
- DOYU N/A
- LAB 48.23
- 52 Week Low
- DOYU $6.29
- LAB $1.17
- 52 Week High
- DOYU $20.17
- LAB $3.04
- Technical
- Relative Strength Index (RSI)
- DOYU 19.08
- LAB 35.51
- Support Level
- DOYU $15.25
- LAB $1.17
- Resistance Level
- DOYU $16.99
- LAB $1.51
- Average True Range (ATR)
- DOYU 0.59
- LAB 0.10
- MACD
- DOYU -0.70
- LAB 0.00
- Stochastic Oscillator
- DOYU 6.23
- LAB 32.50
About DOYU DouYu International Holdings Limited ADS
DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company operates its platform on both PC and mobile apps, through which users can enjoy immersive and interactive games and entertainment live streaming. It generates revenues through live streaming and advertisement.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.